ABOUT US

ABOUT STRATICELL

Based on extensive expertise in skin tissue engineering and cell biology, StratiCELL, founded in 2005, has continuously developed a range of in vitro models and testing solutions to support the development of skin care products. The company has more than 140 customers, including the biggest names in the cosmetics and dermo-pharmaceutical industry.

Driven by a passion for science, StratiCELL researchers work daily to provide scientific data and support innovative claims. Skin models include keratinocytes, fibroblasts, melanocytes, adipocytes, sensory neurons, endothelial cells in monolayer cultures, as well as 3D reconstructed skin under basal, inflammatory, stressed, pathological and other conditions.

The transparency of our studies and the quality of our reports make StratiCELL a leader in product claim substantiation in the field of skin biology. As market players are constantly looking for new concepts, StratiCELL continually offers new models and tests at the cutting edge of innovation.
DISCOVER

OUR TEAM

Michel Salmon

PhD, MBA, Founder & CEO

Coralie Bastin

Project Leader

Aline Chrétien

PhD, Study Director

Sandra Domingo

Management Assistant

Caroline Smal

Study Manager

Roland Hubaux

PhD, R&D Project Manager

Armelle Wauters

PhD, Project Leader

Céline Lancelot

PhD, R&D Scientist

Elowine Thiran

PhD, R&D Scientist

Louise Debry

Ms, Junior Project Leader

Christel Boudry

PhD, Business Developer

DISCOVER

OUR PUBLICATIONS

On the relevance of an in vitro reconstructed human epidermis model for drug screening in atopic dermatitis

OCTOBER 2018

Atopic dermatitis studies through in vitro models

JULY 2017

Methyl-β-cyclodextrin concurs with IL-4, IL-13 and IL-25 to induce alterations reminiscent of atopic dermatitis in reconstructed human epidermis

JUNE 2016

The activation of cultured keratinocytes by cholesterol depletion during reconstruction of a human epidermis is reminiscent of monolayer cultures

JANUARY 2015

The in vitro characterization of a gelatin scaffold, prepared by cryogelation and assessed in vivo as a dermal replacement in wound repair

JULY 2014

Proteomic profiling of human keratinocytes undergoing UVB-induced alternative differentiation reveals TRIpartite motif protein 29 as a survival factor

MAY 2010

IFSCC Congress Munich 2018 - Effective in vitro 3D skin models and gene expression assays to study epidermal barrier resilience after Th-2 and Th-17 driven inflammation

SEPTEMBER 2018

Anti-pollution and in vitro efficiency : overview (Expression Cosmétique)

JULY 2016

MARK-AGE biomarkers of ageing

NOVEMBER 2015

IFSCC Congress Zurich 2015 - In vitro assays to study the effects of air pollutants on skin: exposure to urban dust and cigarette smoke extract

AUGUST 2015

IFSCC Congress Paris 2014 - Identification of skin benefits of a Lepidium meyenii root extract on reconstituted epidermis, using whole transcriptome profiling by DNA microarrays and a new Skin Knowledge Database

SEPTEMBER 2014

UV-induced premature senescence as a model to study photo-aging: a case study with 1,25 Dihydroxyvitamin D3

JULY 2009

IFSCC Congress Munich 2018 - In vitro models to study imbalanced autophagy under basal conditions and glycation stress and its implication in skin aging

AUGUST 2018

Pan-European inter-laboratory studies on a panel of in vitro cytotoxicity and pro-inflammation assays for nanoparticles

NOVEMBER 2016

Reconstructed human epidermis response to urban particulate matter activates multiple stress-related pathways and impacts the skin barrier function

SEPTEMBER 2015

From gene expression data to cosmetic claims (Expression Cosmétique)

DECEMBER 2015

Successful micronucleus testing with the EPI/001 3D reconstructed epidermis model: preliminary findings

MARCH 2012